
Sirolimus (Rapamycin)
Sirolimus is an mTOR-blocking immunosuppressant. Large randomized trials showed that adding it to cyclosporine and steroids cut acute kidney transplant rejection, and a randomized trial in LAM showed it stabilized lung function while it was taken. It has boxed warnings for infection and cancer risk and is not recommended after liver or lung transplant. Grapefruit and live probiotic supplements are the high-severity food and supplement concerns.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Kidney transplant recipients aged 13 or older, and adults with lymphangioleiomyomatosis, whose specialist prescribes sirolimus
Common dosing range
Set by your transplant team or lung specialist and adjusted to blood levels: for example a 6 mg loading dose then 2 mg once daily after a kidney transplant at low to moderate risk, or 2 mg a day to start for LAM
When to expect effects
Blood levels take days to settle because of the long half-life; in the LAM trial, lung function was measured over 12 months
Watch out for
Boxed warnings: higher risk of infection, lymphoma and other cancers; not recommended in liver or lung transplant patients. Avoid grapefruit. Many drugs and some supplements change its blood levels
What is it
Sirolimus (also called rapamycin) is a prescription immunosuppressant taken by mouth as tablets or an oral solution. Its label approves it to prevent organ rejection in people 13 years or older who receive a kidney transplant, used at first together with cyclosporine and corticosteroids, and to treat lymphangioleiomyomatosis (LAM), a rare, slowly progressive lung disease that mostly affects women. Only doctors experienced in immunosuppressive therapy should prescribe it for transplant patients, and its dose is guided by blood-level tests. This page is about the tablets and oral solution, not the sirolimus skin gel or the sirolimus injection, which are separate products with their own labels.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
preventing acute rejection after kidney transplant Good Evidence | Moderate; biopsy-confirmed acute rejection in the first 6 months fell by about 40% to 60% versus azathioprine or placebo | Adults receiving a first kidney transplant, treated together with cyclosporine and corticosteroids | Measured over the first 6 and 12 months after transplant |
kidney function after stopping cyclosporine Good Evidence | Small to moderate gain in kidney function, with more acute rejection | Kidney transplant recipients at low to moderate immunologic risk | Measured 12 months after transplant |
lymphangioleiomyomatosis (LAM) Good Evidence | Moderate; lung function stabilized instead of declining, only while the drug was taken | Adults with LAM and moderate lung impairment | Measured over 12 months of treatment |
preventing acute rejection after kidney transplant
- Effect
- Moderate; biopsy-confirmed acute rejection in the first 6 months fell by about 40% to 60% versus azathioprine or placebo
- Best fit
- Adults receiving a first kidney transplant, treated together with cyclosporine and corticosteroids
- Time
- Measured over the first 6 and 12 months after transplant
kidney function after stopping cyclosporine
- Effect
- Small to moderate gain in kidney function, with more acute rejection
- Best fit
- Kidney transplant recipients at low to moderate immunologic risk
- Time
- Measured 12 months after transplant
lymphangioleiomyomatosis (LAM)
- Effect
- Moderate; lung function stabilized instead of declining, only while the drug was taken
- Best fit
- Adults with LAM and moderate lung impairment
- Time
- Measured over 12 months of treatment
Evidence for 3 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
preventing acute rejection after kidney transplant
Disease adjunctTwo double-blind randomized trials tested sirolimus added to cyclosporine and steroids in first kidney transplant recipients. In 719 patients, the 6-month rate of efficacy failure (biopsy-confirmed acute rejection, graft loss or death) was 18.7% with sirolimus 2 mg a day and 16.8% with 5 mg, versus 32.3% with azathioprine; biopsy-confirmed acute rejection was 16.9% and 12.0% versus 29.8%. In 576 patients, the same composite outcome occurred in 30.0% (2 mg) and 25.6% (5 mg) versus 47.7% on placebo. In the first trial, graft survival (97.2%, 96.0% and 98.1%) and patient survival at 12 months were similar across groups.
Bottom line: Adding sirolimus to cyclosporine and steroids lowered early kidney transplant rejection; 1-year graft and patient survival were similar to azathioprine.
kidney function after stopping cyclosporine
Disease adjunctIn an open-label randomized trial of 430 kidney transplant recipients, patients on sirolimus, cyclosporine and steroids were randomized at 3 months to keep cyclosporine or to stop it and continue sirolimus at higher blood levels. At 12 months, graft survival (95.8% vs 97.2%) and patient survival were similar. Kidney function was better (calculated filtration rate 63 vs 57 mL/min) and blood pressure lower after cyclosporine was withdrawn, but acute rejection after randomization was higher (9.8% vs 4.2%).
Bottom line: Stopping cyclosporine and continuing sirolimus improved kidney function at a cost of more rejection episodes.
lymphangioleiomyomatosis (LAM)
Disease adjunctIn the double-blind MILES trial, 89 patients with LAM and moderate lung impairment took sirolimus or placebo for 12 months. Lung function (FEV1) fell by 12 mL per month on placebo and rose by 1 mL per month on sirolimus; the between-group difference in mean FEV1 change was 153 mL, about 11% of the starting value. Quality of life also improved, but 6-minute walk distance and gas transfer did not differ. After sirolimus was stopped, lung function decline resumed at the placebo rate. Adverse events were more common on sirolimus, while serious adverse events did not differ significantly.
Bottom line: Sirolimus stabilized lung function in LAM for as long as it was taken.
How it works
How to take it
What to track
Bottom line: Your prescriber sets and adjusts the dose by blood level; take it once daily the same way with respect to food, never with grapefruit, and check every supplement first.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Boxed warning: higher risk of infection and possible lymphoma and other cancers, particularly of the skin, from immunosuppression. Over-suppression can lead to opportunistic infections such as tuberculosis, sepsis and fatal infections. Only physicians experienced in immunosuppressive therapy should manage it.
Boxed warning: not recommended after liver transplant. With tacrolimus it was linked to excess deaths and graft loss (22% vs 9%), and with cyclosporine or tacrolimus to more hepatic artery thrombosis (7% vs 2%), most cases leading to graft loss or death.
Boxed warning: not recommended after lung transplant. Cases of bronchial anastomotic dehiscence (breakdown of the airway connection), most fatal, have been reported.
Allergic reactions including anaphylaxis and angioedema (risk may rise with ACE inhibitors), lung inflammation not caused by infection (interstitial lung disease, some fatal), declining kidney function with cyclosporine, protein in the urine, reactivation of latent viruses such as BK virus, and progressive multifocal leukoencephalopathy (PML).
Vaccines: the label says live vaccines (for example measles, mumps, rubella, oral polio, yellow fever, varicella, BCG and oral typhoid) should be avoided during treatment, and that other vaccines may work less well. Ask your transplant team which vaccines you need and when.
Who should avoid it
- People with hypersensitivity to sirolimus (contraindicated)
- Liver or lung transplant recipients (use not recommended)
- Children under 13 for kidney transplant, where safety and efficacy are not established
Pregnancy & breastfeeding
Pregnancy: the label says that, based on animal studies and how it works, sirolimus can cause fetal harm, and that limited human data are not enough to define the risk. Females who could become pregnant are advised to use highly effective contraception before, during and for 12 weeks after stopping sirolimus. The label also says it may impair male and female fertility. Breastfeeding: the label says it is not known whether sirolimus passes into human milk, there are no data on effects on the breastfed infant or milk production, it is present in rat milk, and there is potential for serious adverse effects in breastfed infants; the benefits of breastfeeding should be weighed against the mother's need for the drug.
Interactions
Grapefruit juice blocks CYP3A4, the enzyme that breaks down sirolimus, so blood levels can rise unpredictably. The label says grapefruit juice must not be taken with sirolimus or used to dilute the oral solution, which is mixed only in water or orange juice. If you have had grapefruit, tell your transplant team, who may check a blood level.
In people whose immune system is suppressed, live probiotic organisms can occasionally get into the blood. In a cluster of 6 children after stem cell transplant, the Lactobacillus found in their blood was genetically related to the probiotic they had taken; the report was not a study of sirolimus, and the authors said studies are needed on probiotic safety in immunocompromised patients. Ask your transplant or lung team before taking any probiotic supplement, and report fever or chills promptly.
The label says to avoid sirolimus with strong CYP3A4 or P-gp blockers, which raise its blood levels, and to consider alternatives with less interaction potential. Weaker blockers such as diltiazem, verapamil, fluconazole and some HIV and hepatitis C drugs also raise levels and may need dose changes. Make sure every prescriber knows you take sirolimus.
The label says to avoid these, because they lower sirolimus levels and could leave you under-protected against rejection. Carbamazepine, phenobarbital, phenytoin and rifapentine can also lower levels. Ask your prescriber before starting any of them.
St. John's wort induces CYP3A4 and P-glycoprotein, the enzyme and transporter that clear sirolimus, and the label says there is the potential that it could reduce sirolimus concentrations; it lists the herb among agents that could decrease sirolimus levels. Lower levels can weaken protection against rejection. No study has measured this pair in people. Ask your transplant team before using it in any form, including teas and mood or sleep blends.
The label says sirolimus blood levels may increase with cannabidiol and asks prescribers to monitor levels closely and consider a lower sirolimus dose. In a records review of 25 patients with tuberous sclerosis complex taking cannabidiol as a seizure medicine, sirolimus or everolimus trough levels were higher in 76% after cannabidiol was added, with a median rise of 5.1 ng/mL for sirolimus. Over-the-counter CBD amounts have not been studied. Tell your transplant team before starting or stopping any CBD product.
Cyclosporine raises sirolimus levels. The label recommends taking sirolimus 4 hours after cyclosporine (modified), and says higher sirolimus doses are needed when cyclosporine is withdrawn. The combination can also lower kidney function over time, so kidney tests are watched closely. Your transplant team manages both doses.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I eat grapefruit while taking sirolimus?⌄
No. The label says grapefruit juice must not be taken with sirolimus or used to mix the oral solution, because it blocks the enzyme that breaks sirolimus down and can raise blood levels unpredictably. This page rates it a high-severity interaction. If you have had grapefruit, tell your transplant team.
Can I take probiotics with sirolimus?⌄
This page rates live probiotic supplements a high-severity concern for anyone on immunosuppressants. The evidence is limited: one report describes 6 children after stem cell transplant whose bloodstream Lactobacillus was genetically related to the probiotic they had taken, and it was not a study of sirolimus. Ask your transplant or lung team before taking any probiotic.
Does St. John's wort or CBD affect sirolimus?⌄
The sirolimus label says St. John's wort could lower sirolimus levels, because it speeds up the enzyme and pump that clear sirolimus. It also says CBD (cannabidiol) may raise sirolimus levels, and that blood levels and side effects should be watched closely when the two are used together. Ask your prescriber or pharmacist before using either.
Should I take sirolimus with or without food?⌄
Either, but the same way every time. A high-fat meal raised sirolimus exposure by 23 to 35%, so switching back and forth makes blood levels harder to control. Your team adjusts the dose to your blood levels.
Is sirolimus the same as the rapamycin people take for longevity?⌄
It is the same molecule, but its approved uses are preventing kidney transplant rejection and treating LAM. Anti-aging use is not an approved use, and the label carries boxed warnings for infection and cancer risk. Talk to your doctor before considering any use outside a prescription.
Can I get vaccines while taking sirolimus?⌄
The label says to avoid live vaccines, such as measles, mumps, rubella, yellow fever, varicella and oral typhoid, and that other vaccines may work less well. Ask your transplant team which vaccines you need and when.
References by claim
preventing acute rejection after kidney transplant
kidney function after stopping cyclosporine
Johnson et al., 2001 · PubMed (2001) link
lymphangioleiomyomatosis (LAM)
McCormack et al., 2011 · PMC (2011) link
Safety
Sirolimus tablets prescribing information · DailyMed (FDA label) link
Interaction: Grapefruit and grapefruit juice
Sirolimus oral solution prescribing information · DailyMed (FDA label) link
Interaction: Probiotics (live bacteria or yeast supplements)
Gilliam et al., 2023 · PubMed (2023) link
Interaction: CBD (cannabidiol, including Epidiolex)
Ebrahimi-Fakhari et al., 2020 · PubMed (2020) link
Track Sirolimus (Rapamycin) with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
